FeesSafety
Pluang+

Crypto trader linked to Huang Licheng suffers $111,500 loss in 7 days amid Ether market drop

Technical Signals
27 Oct 2026, 01:20 WIB
Tokenpost
View Source
Bearish
Crypto trader linked to Huang Licheng suffers $111,500 loss in 7 days amid Ether market drop

An address connected to Huang Licheng, known as "麻吉大哥," held a leveraged long position of 68 Ether (ETH) with 25x leverage. The position entered at $2,313.88 per ETH and faced liquidation risk at $2,290.41. During the market decline on October 24, the address experienced multiple liquidations, resulting in nearly $40,000 lost in one event. Over the past seven days, the total losses reached $111,500, contributing to a cumulative historical loss of $35.37 million. This highlights the high risks of leveraged trading in volatile crypto markets.

The story about an address linked to Huang Licheng holding a leveraged long position in Ether provides context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 27, 2026 05:02 WIB: out of 50 priced major cryptocurrencies tradable on Pluang, 24 rose and 24 fell today. Notable movers include SXP (Solar) down 46.27% to Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% to Rp16,297 with a typical hold time of 85 days, and EOS (EOS.IO) up 8.13% to Rp12,649 with a typical hold time of 87 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App